{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:16:08Z","timestamp":1779286568826,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82074493"],"award-info":[{"award-number":["No.82074493"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["No.202300410266"],"award-info":[{"award-number":["No.202300410266"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["2024ZY1002"],"award-info":[{"award-number":["2024ZY1002"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["2022JDZX003"],"award-info":[{"award-number":["2022JDZX003"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"other","award":["No. YUWMZYH [2021] No. 8"],"award-info":[{"award-number":["No. YUWMZYH [2021] No. 8"]}]},{"name":"other","award":["NO. 2023ZYZD02"],"award-info":[{"award-number":["NO. 2023ZYZD02"]}]},{"name":"other","award":["RCTAIIRHSPN001"],"award-info":[{"award-number":["RCTAIIRHSPN001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10067-026-07946-x","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:10:27Z","timestamp":1769091027000},"page":"1801-1811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Telitacicept for childhood HSPN: A prospective self-controlled study"],"prefix":"10.1007","volume":"45","author":[{"given":"Hanhan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8589-1917","authenticated-orcid":false,"given":"Chundong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenchen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caixia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"7946_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2025.110443","volume":"272","author":"WH Zhou","year":"2025","unstructured":"Zhou WH, Zheng ML, Hu Z et al (2025) Single-cell transcriptomics reveals the alteration of immune cell profile in peripheral blood of Henoch-Schonlein purpura. Clin Immunol 272:110443. https:\/\/doi.org\/10.1016\/j.clim.2025.110443","journal-title":"Clin Immunol"},{"issue":"7","key":"7946_CR2","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/S00431-024-05573-9","volume":"183","author":"M Yu","year":"2024","unstructured":"Yu M, Song XX, Guo J et al (2024) Exploring potential predictors of Henoch-Sch\u00f6nlein purpura nephritis: a pilot investigation on urinary metabolites. Eur J Pediatr 183(7):3117\u20133128. https:\/\/doi.org\/10.1007\/S00431-024-05573-9","journal-title":"Eur J Pediatr"},{"key":"7946_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/FPED.2022.1029520","volume":"10","author":"Y Cao","year":"2022","unstructured":"Cao Y, Shen T, Li YZ et al (2022) A retrospective study on the characteristics of renal pathological grades in HSPN children with mild to moderate proteinuria. Front Pediatr 10:1029520. https:\/\/doi.org\/10.3389\/FPED.2022.1029520","journal-title":"Front Pediatr"},{"issue":"1","key":"7946_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-021-03415-x","volume":"21","author":"X Xue","year":"2021","unstructured":"Xue X, Liu XH, Lu CL, Jin XY, Liu Q, Wang XQ, Liu JP (2021) Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: a systematic review of randomized controlled trials. BMC Complement Med Ther 21(1):278. https:\/\/doi.org\/10.1186\/s12906-021-03415-x","journal-title":"BMC Complement Med Ther"},{"key":"7946_CR5","doi-asserted-by":"publisher","unstructured":"Bai MK, Yang XQ, Li H, et al (2024) Analysis of laboratory parameters and pathological features in children with Henoch-Sch\u00f6nlein purpura nephritis complicated by crescent formation. Tianjin Med J 52(8):820\u2013824. https:\/\/doi.org\/10.11958\/20231860","DOI":"10.11958\/20231860"},{"issue":"30","key":"7946_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039059","volume":"103","author":"D Wang","year":"2024","unstructured":"Wang D, Liu TQ, Lu JK et al (2024) Efficacy and safety of mycophenolate mofetil versus cyclophosphamide therapy for Henoch schonlein purpura nephritis in children: a meta-analysis. Medicine (Baltimore) 103(30):e39059. https:\/\/doi.org\/10.1097\/MD.0000000000039059","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"7946_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04353-3","volume":"26","author":"T Xie","year":"2025","unstructured":"Xie T, Ding Y, Liu F (2025) Efficacy and safety of tacrolimus in the treatment of Henoch-Sch\u00f6nlein purpura nephritis: systematic review and meta-analysis. BMC Nephrol 26(1):463. https:\/\/doi.org\/10.1186\/s12882-025-04353-3","journal-title":"BMC Nephrol"},{"key":"7946_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.MICPATH.2021.105192","volume":"160","author":"S Pang","year":"2021","unstructured":"Pang S, Zhao S, Bai X et al (2021) Variations of tongue coating microbiota in children with Henoch-Sch\u00f6nlein purpura nephritis. Microb Pathog 160:105192. https:\/\/doi.org\/10.1016\/J.MICPATH.2021.105192","journal-title":"Microb Pathog"},{"key":"7946_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/FNEPH.2023.1346769","volume":"3","author":"CK Cheung","year":"2024","unstructured":"Cheung CK, Barratt J, Liew A et al (2024) The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies. Front Nephrol 3:1346769. https:\/\/doi.org\/10.3389\/FNEPH.2023.1346769","journal-title":"Front Nephrol"},{"issue":"1","key":"7946_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-021-91055-Z","volume":"11","author":"D Prieto-Pe\u00f1a","year":"2021","unstructured":"Prieto-Pe\u00f1a D, Genre F, Remuzgo-Mart\u00ednez S et al (2021) BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis. Sci Rep 11(1):11510. https:\/\/doi.org\/10.1038\/S41598-021-91055-Z","journal-title":"Sci Rep"},{"key":"7946_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1169084","volume":"14","author":"J Cai","year":"2023","unstructured":"Cai J, Gao D, Liu D et al (2023) Telitacicept for autoimmune nephropathy. Front Immunol 14:1169084. https:\/\/doi.org\/10.3389\/FIMMU.2023.1169084","journal-title":"Front Immunol"},{"issue":"1","key":"7946_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/S40001-023-01320-2","volume":"28","author":"LJ Wu","year":"2023","unstructured":"Wu LJ, Du XR, Lu XH (2023) Role of telitacicept in the treatment of IgA nephropathy. Eur J Med Res 28(1):369. https:\/\/doi.org\/10.1186\/S40001-023-01320-2","journal-title":"Eur J Med Res"},{"issue":"3","key":"7946_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003297","volume":"9","author":"I Parodis","year":"2023","unstructured":"Parodis I, Gomez A, Tsoi A, Chow JW, Pezzella D, Girard C, Stamm TA, Bostr\u00f6m C (2023) Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. RMD Open 9(3):e003297. https:\/\/doi.org\/10.1136\/rmdopen-2023-003297","journal-title":"RMD Open"},{"issue":"14","key":"7946_CR14","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/S40265-021-01591-1","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S (2021) Telitacicept: first approval. Drugs 81(14):1671\u20131675. https:\/\/doi.org\/10.1007\/S40265-021-01591-1","journal-title":"Drugs"},{"key":"7946_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPS.2021.105704","volume":"159","author":"XT Yao","year":"2021","unstructured":"Yao XT, Ren YR, Zhao Q et al (2021) Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS\/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis. Eur J Pharm Sci 159:105704. https:\/\/doi.org\/10.1016\/J.EJPS.2021.105704","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"7946_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3760\/cma.j.issn.0578-1310.2017.09.003","volume":"55","author":"Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association","year":"2017","unstructured":"Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association (2017) Evidence-based guideline for diagnosis and treatment of Henoch-Schonlein purpura nephritis (2016). Chin J Pediatr 55(9):647\u2013651. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2017.09.003","journal-title":"Chin J Pediatr"},{"issue":"1","key":"7946_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0254-6272(14)60048-0","volume":"34","author":"D Ding","year":"2014","unstructured":"Ding D, Yan H, Zhen X (2014) Effects of Chinese herbs in children with Henoch-Schonlein purpura nephritis: a randomized controlled trial. J Tradit Chin Med 34(1):15\u201322. https:\/\/doi.org\/10.1016\/s0254-6272(14)60048-0","journal-title":"J Tradit Chin Med"},{"issue":"4","key":"7946_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/S40272-022-00506-1","volume":"24","author":"DY Wu","year":"2022","unstructured":"Wu DY, Ma R, Wang XM et al (2022) Efficacy and safety of tacrolimus in the treatment of pediatric Henoch-Sch\u00f6nlein purpura nephritis. Paediatr Drugs 24(4):389\u2013401. https:\/\/doi.org\/10.1007\/S40272-022-00506-1","journal-title":"Paediatr Drugs"},{"issue":"1","key":"7946_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J et al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83(1):15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7946_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/S00467-022-05585-3","volume":"38","author":"D Wu","year":"2023","unstructured":"Wu D, Lei L, Zhang HJ et al (2023) Clinical relevance of glomerular C4d deposition in children with early IgA nephropathy or Henoch-Sch\u00f6nlein purpura nephropathy. Pediatr Nephrol 38(2):431\u2013438. https:\/\/doi.org\/10.1007\/S00467-022-05585-3","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"7946_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41390-020-0951-1","volume":"89","author":"H Irabu","year":"2021","unstructured":"Irabu H, Shimizu M, Kaneko S et al (2021) Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura nephritis. Pediatr Res 89(3):667\u2013672. https:\/\/doi.org\/10.1038\/s41390-020-0951-1","journal-title":"Pediatr Res"},{"issue":"1","key":"7946_CR22","doi-asserted-by":"publisher","DOI":"10.1515\/BIOL-2022-0812","volume":"19","author":"LH Jia","year":"2024","unstructured":"Jia LH, Li XZ, Shen JY et al (2024) Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Sch\u00f6nlein purpura and pediatric-onset systemic lupus erythematous. Open Life Sci 19(1):20220812. https:\/\/doi.org\/10.1515\/BIOL-2022-0812","journal-title":"Open Life Sci"},{"issue":"11","key":"7946_CR23","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"K Marianthi","year":"2020","unstructured":"Marianthi K, Lee CC (2020) Systemic lupus erythematosus. Ann Intern Med 172(11):ITC81\u2013ITC96. https:\/\/doi.org\/10.7326\/AITC202006020","journal-title":"Ann Intern Med"},{"issue":"3","key":"7946_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/J.EKIR.2022.12.014","volume":"8","author":"JC Lv","year":"2022","unstructured":"Lv JC, Liu LJ, Hao CM et al (2022) Randomized phase 2 trial of Telitacicept in patients with IgA nephropathy with persistent proteinuria. Kidney Int Rep 8(3):499\u2013506. https:\/\/doi.org\/10.1016\/J.EKIR.2022.12.014","journal-title":"Kidney Int Rep"},{"issue":"1","key":"7946_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2449580","volume":"47","author":"LQ Dong","year":"2025","unstructured":"Dong LQ, Yang DD, Qin AY et al (2025) Efficacy and safety of telitacicept in IgA nephropathy: a real-world study. Ren Fail 47(1):2449580. https:\/\/doi.org\/10.1080\/0886022X.2025.2449580","journal-title":"Ren Fail"},{"key":"7946_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1564242","volume":"16","author":"SX Li","year":"2025","unstructured":"Li SX, Hu RK, Kong DL et al (2025) Efficacy of telitacicept in treating IgA vasculitis nephritis: a two-case report. Front Immunol 16:1564242. https:\/\/doi.org\/10.3389\/fimmu.2025.1564242","journal-title":"Front Immunol"},{"issue":"29","key":"7946_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000043358","volume":"104","author":"W Jiang","year":"2025","unstructured":"Jiang W, Li X, Liu X et al (2025) Efficacy and safety of tacrolimus versus cyclophosphamide therapy for Henoch-Sch\u00f6nlein purpura nephritis in children: a systematic review. Medicine (Baltimore) 104(29):e43358. https:\/\/doi.org\/10.1097\/md.0000000000043358","journal-title":"Medicine (Baltimore)"},{"key":"7946_CR28","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.2147\/dddt.s528565","volume":"19","author":"Y Han","year":"2025","unstructured":"Han Y, Yang F, Zhou L et al (2025) Efficacy and long-term outcomes of tacrolimus versus cyclophosphamide and mycophenolate mofetil in the management of pediatric IgA vasculitis nephritis: a cohort study in single-center. Drug Des Devel Ther 19:6413\u20136422. https:\/\/doi.org\/10.2147\/dddt.s528565","journal-title":"Drug Des Devel Ther"},{"key":"7946_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2798217","volume":"2022","author":"QQ Liu","year":"2022","unstructured":"Liu QQ, Liu JH, Du YY et al (2022) Network pharmacology and molecular docking analysis to explore the mechanism of Huaiqihuang-mediated alleviation of Henoch-Sch\u00f6nlein purpura nephritis. Biomed Res Int 2022:2798217. https:\/\/doi.org\/10.1155\/2022\/2798217","journal-title":"Biomed Res Int"},{"issue":"8","key":"7946_CR30","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00467-025-06769-3","volume":"40","author":"Y Jin","year":"2025","unstructured":"Jin Y, Zhu J, Sheng A et al (2025) Telitacicept as a BAFF\/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis. Pediatr Nephrol 40(8):2561\u20132569. https:\/\/doi.org\/10.1007\/s00467-025-06769-3","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"7946_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-025-01159-3","volume":"23","author":"XQ Ma","year":"2025","unstructured":"Ma XQ, He YH, Shao PP et al (2025) Efficacy and safety of telitacicept in children with IgA vasculitis and IgA vasculitis nephritis: a single-center retrospective study. Pediatr Rheumatol Online J 23(1):104. https:\/\/doi.org\/10.1186\/s12969-025-01159-3","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07946-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07946-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07946-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:45:20Z","timestamp":1779241520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07946-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7946"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07946-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures have been approved by the Ethics Review Committee of The First Affiliated Hospital of Henan University of Chinese Medicine (Ethical Approval.: No. 2023HL-313\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants signed the informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}